NPI: 1023064482 · MILWAUKEE, WI 53211 · Family Medicine Physician · NPI assigned 05/26/2006
Authorized official MCCULLOUGH, MICHAEL controls 20+ related entities in our dataset. Read more
| Authorized Official | MCCULLOUGH, MICHAEL (CFO) |
| NPI Enumeration Date | 05/26/2006 |
Other providers sharing the same authorized official: MCCULLOUGH, MICHAEL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 71,985 | $1.44M |
| 2019 | 76,166 | $1.39M |
| 2020 | 62,722 | $1.31M |
| 2021 | 74,109 | $1.51M |
| 2022 | 60,625 | $1.40M |
| 2023 | 59,482 | $1.43M |
| 2024 | 37,525 | $1.33M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 127,020 | 110,569 | $4.23M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 67,899 | 58,657 | $1.59M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8,759 | 7,714 | $489K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 70,498 | 55,077 | $413K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6,113 | 5,733 | $347K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 8,798 | 8,029 | $271K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2,501 | 2,281 | $201K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4,125 | 3,725 | $152K |
| 99233 | Prolong inpt eval add15 m | 7,247 | 1,811 | $135K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 4,103 | 3,416 | $121K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1,921 | 1,842 | $112K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 4,130 | 3,880 | $111K |
| 90834 | Psychotherapy, 45 minutes with patient | 2,470 | 1,286 | $85K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1,709 | 1,164 | $83K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 984 | 850 | $82K |
| 11721 | 8,207 | 7,341 | $81K | |
| 99215 | Prolong outpt/office vis | 2,180 | 1,860 | $80K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1,006 | 932 | $71K |
| 90686 | 7,339 | 6,896 | $69K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,191 | 1,071 | $59K |
| 76819 | Fetal biophysical profile; without non-stress testing | 1,916 | 1,610 | $59K |
| 99000 | 17,345 | 14,287 | $49K | |
| 93356 | 2,741 | 2,516 | $46K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,130 | 1,055 | $43K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,127 | 1,051 | $41K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,476 | 2,033 | $38K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 2,331 | 1,002 | $31K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 891 | 842 | $30K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 509 | 343 | $24K |
| 3008F | 2,783 | 2,653 | $24K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,802 | 2,600 | $23K |
| 95886 | 291 | 264 | $21K | |
| 80305 | 1,786 | 1,482 | $20K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 776 | 476 | $20K |
| 93296 | 2,086 | 1,929 | $19K | |
| 90670 | 4,404 | 4,082 | $19K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 431 | 398 | $18K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 314 | 295 | $18K |
| 80061 | Lipid panel | 1,385 | 1,290 | $18K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 64 | 37 | $18K |
| 99239 | Hospital discharge day management, more than 30 minutes | 335 | 271 | $17K |
| 95720 | 176 | 66 | $16K | |
| 16020 | 841 | 572 | $16K | |
| 90648 | 3,121 | 2,891 | $15K | |
| 11056 | 1,161 | 994 | $14K | |
| 11057 | 780 | 690 | $14K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 361 | 318 | $13K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 13 | 12 | $13K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9,927 | 9,314 | $13K |
| 93298 | 979 | 874 | $12K | |
| 90723 | 2,473 | 2,271 | $12K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 1,370 | 399 | $11K |
| 92557 | 520 | 457 | $11K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 98 | 83 | $11K |
| 90791 | Psychiatric diagnostic evaluation | 239 | 177 | $10K |
| 99243 | 172 | 166 | $10K | |
| 93295 | 410 | 372 | $8K | |
| 0002A | 235 | 225 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 242 | 226 | $8K |
| 31575 | 144 | 138 | $8K | |
| 90680 | 1,644 | 1,526 | $8K | |
| 80053 | Comprehensive metabolic panel | 736 | 670 | $7K |
| 95971 | 379 | 350 | $7K | |
| 93042 | 2,175 | 1,047 | $7K | |
| 59025 | Fetal non-stress test | 309 | 153 | $7K |
| 95819 | 371 | 323 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 259 | 248 | $7K |
| 77427 | 82 | 37 | $7K | |
| 0001A | 227 | 222 | $7K | |
| 90656 | 333 | 325 | $6K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 477 | 418 | $6K |
| 95974 | 61 | 45 | $5K | |
| 93018 | 544 | 507 | $5K | |
| 99223 | Prolong inpt eval add15 m | 137 | 127 | $5K |
| 90750 | 33 | 31 | $5K | |
| 90461 | 5,297 | 4,968 | $4K | |
| 36224 | 18 | 14 | $4K | |
| 90715 | 139 | 131 | $4K | |
| 90633 | 617 | 579 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 66 | 61 | $4K |
| 93294 | 460 | 426 | $4K | |
| 88141 | 177 | 166 | $3K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 173 | 152 | $3K |
| 76377 | 126 | 125 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 15 | 12 | $3K |
| 93299 | 48 | 40 | $3K | |
| 99385 | 62 | 53 | $3K | |
| 90647 | 527 | 487 | $3K | |
| 99442 | 313 | 221 | $3K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 14 | 13 | $3K |
| 90677 | 208 | 184 | $3K | |
| 93000 | 270 | 240 | $3K | |
| 87070 | 234 | 212 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 324 | 302 | $2K |
| 99152 | 141 | 111 | $2K | |
| 98929 | 50 | 41 | $2K | |
| 83655 | 165 | 160 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 33 | 26 | $2K |
| 52000 | 12 | 12 | $2K | |
| 99254 | 34 | 29 | $2K | |
| 93016 | 143 | 131 | $2K | |
| 90674 | 85 | 85 | $2K | |
| 99242 | 40 | 38 | $2K | |
| 81003 | 931 | 627 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | 126 | 106 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 56 | 52 | $2K |
| 99460 | 21 | 14 | $2K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 58 | 52 | $2K |
| 99205 | Prolong outpt/office vis | 26 | 26 | $2K |
| 76376 | 279 | 246 | $1K | |
| 76820 | 64 | 52 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 157 | 149 | $1K |
| 94729 | 299 | 275 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 84 | 38 | $1K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 571 | 520 | $1K |
| 90710 | 98 | 96 | $1K | |
| 94060 | 158 | 138 | $1K | |
| 94727 | 183 | 168 | $1K | |
| 96127 | 284 | 263 | $981.76 | |
| 81025 | 142 | 122 | $944.57 | |
| 80081 | 12 | 12 | $882.67 | |
| 90685 | 285 | 252 | $877.43 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 69 | 59 | $870.61 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 60 | 28 | $838.76 |
| 99407 | 349 | 281 | $802.40 | |
| 90662 | 31 | 26 | $772.50 | |
| 86803 | 55 | 49 | $732.12 | |
| 85027 | 105 | 99 | $705.54 | |
| 73630 | 36 | 27 | $704.01 | |
| 31231 | 13 | 12 | $678.17 | |
| 36415 | Collection of venous blood by venipuncture | 5,547 | 4,837 | $629.70 |
| 20611 | 16 | 12 | $604.28 | |
| 84443 | Thyroid stimulating hormone (TSH) | 42 | 38 | $594.02 |
| 20610 | 17 | 12 | $578.75 | |
| 99443 | 20 | 15 | $562.28 | |
| 96132 | 25 | 13 | $545.36 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 96 | 77 | $541.91 |
| 99238 | Hospital discharge day management, 30 minutes or less | 15 | 13 | $539.25 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 19 | 16 | $521.82 |
| 0072A | 13 | 12 | $478.92 | |
| 94726 | 70 | 67 | $465.42 | |
| 95806 | 12 | 12 | $440.03 | |
| 0124A | 13 | 13 | $433.88 | |
| 90480 | 16 | 12 | $433.12 | |
| 80050 | General health panel | 13 | 12 | $423.88 |
| 96133 | 16 | 12 | $416.40 | |
| 90734 | 28 | 28 | $402.15 | |
| 99222 | Initial hospital care, per day, moderate complexity | 47 | 37 | $400.74 |
| 94690 | 77 | 70 | $400.20 | |
| 90651 | 73 | 69 | $389.85 | |
| 99188 | 32 | 29 | $385.07 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 27 | 25 | $382.33 |
| 83037 | 128 | 101 | $381.24 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 130 | 106 | $368.49 |
| 90696 | 25 | 25 | $354.00 | |
| 11720 | 61 | 52 | $348.09 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 12 | 12 | $330.10 |
| 90681 | 100 | 89 | $299.65 | |
| 95977 | 16 | 12 | $272.26 | |
| 87077 | 28 | 26 | $247.35 | |
| 99406 | 47 | 42 | $241.57 | |
| 69210 | 29 | 25 | $221.35 | |
| 96161 | 70 | 60 | $215.81 | |
| 87081 | 26 | 24 | $210.76 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 16 | 14 | $184.24 |
| 92567 | 14 | 14 | $164.26 | |
| 82950 | 28 | 28 | $157.17 | |
| 99441 | 56 | 16 | $133.63 | |
| 93280 | 18 | 12 | $121.19 | |
| 76937 | 15 | 13 | $120.12 | |
| 51798 | 14 | 12 | $106.82 | |
| 96136 | 15 | 12 | $101.84 | |
| 93040 | 12 | 12 | $98.01 | |
| 87147 | 13 | 12 | $77.00 | |
| 84460 | 14 | 13 | $57.21 | |
| 84450 | 14 | 13 | $55.85 | |
| 81001 | 16 | 15 | $55.38 | |
| 85018 | 12 | 12 | $32.41 | |
| 85014 | 12 | 12 | $31.41 | |
| 93325 | 17 | 14 | $30.77 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | 12 | $26.50 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2,035 | 1,851 | $13.11 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 34 | 26 | $2.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 617 | 523 | $1.67 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 12 | 12 | $1.12 |
| 91300 | 516 | 428 | $0.74 | |
| 91312 | 12 | 12 | $0.03 | |
| 0500F | 12 | 12 | $0.00 | |
| 91307 | 17 | 17 | $0.00 | |
| 0502F | 659 | 487 | $0.00 |